# L_2014167EN.01003601.xml

| 6.6.2014 | EN | Official Journal of the European Union | L 167/36 |
| --- | --- | --- | --- |

6.6.2014

EN

Official Journal of the European Union

L 167/36

---

COMMISSION REGULATION (EU) No 605/2014

of 5 June 2014

amending, for the purposes of introducing hazard and precautionary statements in the Croatian language and its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to the Act concerning the conditions of accession of the Republic of Croatia and the adjustments to the Treaty on European Union and the Treaty establishing the European Atomic Energy Community (1), and in particular Article 50 thereof,

Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (2), and in particular Article 37(5) thereof,

Whereas:

| (1) | Commission Regulation (EU) No 487/2013 (3) amends some of the language tables for hazard statements included in Annex III to Regulation (EC) No 1272/2008 and some of the language tables for precautionary statements included in Annex IV to that Regulation. With the accession of Croatia to the European Union on 1 July 2013, it is necessary that all hazard and precautionary statements provided for by Regulation (EC) No 1272/2008 as amended by Commission Regulation (EU) No 487/2013 are available in the Croatian language as well. This Regulation introduces the necessary adjustments to the language tables. |
| --- | --- |

(1)

Commission Regulation (EU) No 487/2013 (3) amends some of the language tables for hazard statements included in Annex III to Regulation (EC) No 1272/2008 and some of the language tables for precautionary statements included in Annex IV to that Regulation. With the accession of Croatia to the European Union on 1 July 2013, it is necessary that all hazard and precautionary statements provided for by Regulation (EC) No 1272/2008 as amended by Commission Regulation (EU) No 487/2013 are available in the Croatian language as well. This Regulation introduces the necessary adjustments to the language tables.

| (2) | Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC (4). |
| --- | --- |

(2)

Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC (4).

| (3) | Proposals for new or updated harmonised classification and labelling of certain substances have been submitted to the European Chemicals Agency (ECHA) pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those proposals issued by the Committee for Risk Assessment of ECHA, as well as on the comments received from the parties concerned, it is appropriate to introduce, remove or update harmonised classification and labelling of certain substances by amending Annex VI to that Regulation. |
| --- | --- |

(3)

Proposals for new or updated harmonised classification and labelling of certain substances have been submitted to the European Chemicals Agency (ECHA) pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those proposals issued by the Committee for Risk Assessment of ECHA, as well as on the comments received from the parties concerned, it is appropriate to introduce, remove or update harmonised classification and labelling of certain substances by amending Annex VI to that Regulation.

| (4) | Compliance with the new harmonised classifications should not be required immediately, as a certain period of time will be necessary to allow suppliers to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow suppliers to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council (5). |
| --- | --- |

(4)

Compliance with the new harmonised classifications should not be required immediately, as a certain period of time will be necessary to allow suppliers to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow suppliers to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council (5).

| (5) | In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the new harmonised classifications and of adapting the labelling and packaging accordingly on a voluntary basis before the deadline for compliance. |
| --- | --- |

(5)

In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the new harmonised classifications and of adapting the labelling and packaging accordingly on a voluntary basis before the deadline for compliance.

| (6) | The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006, |
| --- | --- |

(6)

The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,

HAS ADOPTED THIS REGULATION:

Article 1

Regulation (EC) No 1272/2008 is amended as follows:

| (1) | Annex III is amended in accordance with Annex I to this Regulation; |
| --- | --- |

(1)

Annex III is amended in accordance with Annex I to this Regulation;

| (2) | Annex IV is amended in accordance with Annex II to this Regulation; |
| --- | --- |

(2)

Annex IV is amended in accordance with Annex II to this Regulation;

| (3) | Annex VI is amended in accordance with Annex III to this Regulation. |
| --- | --- |

(3)

Annex VI is amended in accordance with Annex III to this Regulation.

Article 2

1.   By way of derogation from Article 3(2), substances and mixtures may, before 1 December 2014 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with this Regulation.

2.   By way of derogation from Article 3(2), substances classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 and placed on the market before 1 December 2014, shall not be required to be relabelled and repackaged in accordance with this Regulation until 1 December 2016.

3.   By way of derogation from Article 3(2), mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC of the European Parliament and of the Council (6) or Regulation (EC) No 1272/2008 and placed on the market before 1 June 2015, shall not be required to be relabelled and repackaged in accordance with this Regulation until 1 June 2017.

4.   By way of derogation from Article 3(3), the harmonised classifications set out in Annex III to this Regulation may be applied before the date referred to in Article 3(3).

Article 3

1.   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

2.   Article 1(1) and (2) shall apply in respect of substances from 1 December 2014 and in respect of mixtures from 1 June 2015.

3.   Article 1(3) shall apply from 1 April 2015.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 June 2014.

For the Commission

The President

José Manuel BARROSO

---

(1)  
  OJ L 112, 24.4.2012, p. 21.

1

(2)  
  OJ L 353, 31.12.2008, p. 1.

2

(3)  Commission Regulation (EU) No 487/2013 of 8 May 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and the Council on classification, labelling and packaging of substances and mixtures (OJ L 149, 1.6.2013, p. 1).

3

(4)  Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ L 196, 16.8.1967, p. 1).

4

(5)  Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).

5

(6)  Directive 1999/45/EC of the European Parliament and of the Council of 31 May 1999 concerning the approximation of the laws, regulations and administrative provisions of the Member States relating to the classification, packaging and labelling of dangerous preparations (OJ L 200, 30.7.1999, p. 1).

6

---

ANNEX I

In Part 1 of Annex III, Table 1.1 is amended as follows:

| (1) | in code H229, the following is inserted after the entry corresponding to GA: | ‘HR | Spremnik pod tlakom: može se rasprsnuti ako se grije.’ |
| --- | --- | --- | --- |

(1)

in code H229, the following is inserted after the entry corresponding to GA:

‘HR

Spremnik pod tlakom: može se rasprsnuti ako se grije.’

| (2) | in code H230, the following is inserted after the entry corresponding to GA: | ‘HR | Može eksplozivno reagirati i bez prisustva zraka.’ |
| --- | --- | --- | --- |

(2)

in code H230, the following is inserted after the entry corresponding to GA:

‘HR

Može eksplozivno reagirati i bez prisustva zraka.’

| (3) | in code H231, the following is inserted after the entry corresponding to GA: | ‘HR | Može eksplozivno reagirati i bez prisustva zraka na povišenom tlaku i/ili temperaturi.’ |
| --- | --- | --- | --- |

(3)

in code H231, the following is inserted after the entry corresponding to GA:

‘HR

Može eksplozivno reagirati i bez prisustva zraka na povišenom tlaku i/ili temperaturi.’

---

ANNEX II

Part 2 to Annex IV is amended as follows:

| (1) | Table 1.2 is amended as follows:






  (a) | in code P210, the following is inserted after the entry corresponding to GA: | ‘HR | Čuvati odvojeno od topline, vrućih površina, iskri, otvorenih plamena i ostalih izvora paljenja. Ne pušiti.’ |
| --- | --- | --- | --- | --- |

(1)

Table 1.2 is amended as follows:

(a)

in code P210, the following is inserted after the entry corresponding to GA:

‘HR

Čuvati odvojeno od topline, vrućih površina, iskri, otvorenih plamena i ostalih izvora paljenja. Ne pušiti.’

| (b) | in code P223: The following is inserted after the entry corresponding to GA: | ‘HR | Spriječiti dodir s vodom.’ |
| --- | --- | --- | --- |

(b)

in code P223: The following is inserted after the entry corresponding to GA:

‘HR

Spriječiti dodir s vodom.’

| (c) | in code P244, the following is inserted after the entry corresponding to GA: | ‘HR | Spriječiti dodir ventila i spojnica s uljem i masti.’ |
| --- | --- | --- | --- |

(c)

in code P244, the following is inserted after the entry corresponding to GA:

‘HR

Spriječiti dodir ventila i spojnica s uljem i masti.’

| (d) | in code P251, the following is inserted after the entry corresponding to GA: | ‘HR | Ne bušiti, niti paliti čak niti nakon uporabe.’ |
| --- | --- | --- | --- |

(d)

in code P251, the following is inserted after the entry corresponding to GA:

‘HR

Ne bušiti, niti paliti čak niti nakon uporabe.’

| (e) | in code P284, the following is inserted after the entry corresponding to GA: | ‘HR | [U slučaju nedovoljne ventilacije] nositi sredstva za zaštitu dišnog sustava.’ |
| --- | --- | --- | --- |

(e)

in code P284, the following is inserted after the entry corresponding to GA:

‘HR

[U slučaju nedovoljne ventilacije] nositi sredstva za zaštitu dišnog sustava.’

| (2) | Table 1.3 is amended as follows:






  (a) | in code P310, the following is inserted after the entry corresponding to GA: | ‘HR | Odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’ |
| --- | --- | --- | --- | --- |

(2)

Table 1.3 is amended as follows:

(a)

in code P310, the following is inserted after the entry corresponding to GA:

‘HR

Odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’

| (b) | in code P 311, the following is inserted after the entry corresponding to GA: | ‘HR | Nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’ |
| --- | --- | --- | --- |

(b)

in code P 311, the following is inserted after the entry corresponding to GA:

‘HR

Nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’

| (c) | in code P312: The following is inserted after the entry corresponding to GA: | ‘HR | U slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’ |
| --- | --- | --- | --- |

(c)

in code P312: The following is inserted after the entry corresponding to GA:

‘HR

U slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’

| (d) | in code P340, the following is inserted after the entry corresponding to GA: | ‘HR | Premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.’ |
| --- | --- | --- | --- |

(d)

in code P340, the following is inserted after the entry corresponding to GA:

‘HR

Premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.’

| (e) | in code P352, the following is inserted after the entry corresponding to GA: | ‘HR | Oprati velikom količinom vode/...’ |
| --- | --- | --- | --- |

(e)

in code P352, the following is inserted after the entry corresponding to GA:

‘HR

Oprati velikom količinom vode/...’

| (f) | in code P361, the following is inserted after the entry corresponding to GA: | ‘HR | Odmah skinuti svu zagađenu odjeću.’ |
| --- | --- | --- | --- |

(f)

in code P361, the following is inserted after the entry corresponding to GA:

‘HR

Odmah skinuti svu zagađenu odjeću.’

| (g) | in code P362, the following is inserted after the entry corresponding to GA: | ‘HR | Skinuti zagađenu odjeću.’ |
| --- | --- | --- | --- |

(g)

in code P362, the following is inserted after the entry corresponding to GA:

‘HR

Skinuti zagađenu odjeću.’

| (h) | in code P364, the following is inserted after the entry corresponding to GA: | ‘HR | I oprati je prije ponovne uporabe.’ |
| --- | --- | --- | --- |

(h)

in code P364, the following is inserted after the entry corresponding to GA:

‘HR

I oprati je prije ponovne uporabe.’

| (i) | in code P378, the following is inserted after the entry GA: | ‘HR | Za gašenje rabiti ...’ |
| --- | --- | --- | --- |

(i)

in code P378, the following is inserted after the entry GA:

‘HR

Za gašenje rabiti ...’

| (j) | in combined codes P301 + P310, the following is inserted after the entry corresponding to GA: | ‘HR | AKO SE PROGUTA: odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’ |
| --- | --- | --- | --- |

(j)

in combined codes P301 + P310, the following is inserted after the entry corresponding to GA:

‘HR

AKO SE PROGUTA: odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’

| (k) | in combined codes P301 + P312, the following is inserted after the entry corresponding to GA: | ‘HR | AKO SE PROGUTA: u slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’ |
| --- | --- | --- | --- |

(k)

in combined codes P301 + P312, the following is inserted after the entry corresponding to GA:

‘HR

AKO SE PROGUTA: u slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’

| (l) | in combined codes P302 + P352, the following is inserted after the entry corresponding to GA: | ‘HR | U SLUČAJU DODIRA S KOŽOM: oprati velikom količinom vode/...’ |
| --- | --- | --- | --- |

(l)

in combined codes P302 + P352, the following is inserted after the entry corresponding to GA:

‘HR

U SLUČAJU DODIRA S KOŽOM: oprati velikom količinom vode/...’

| (m) | in combined codes P303 + P361+P353, the following is inserted after the entry corresponding to GA: | ‘HR | U SLUČAJU DODIRA S KOŽOM (ili kosom): odmah skinuti svu zagađenu odjeću. Isprati kožu vodom/tuširanjem.’ |
| --- | --- | --- | --- |

(m)

in combined codes P303 + P361+P353, the following is inserted after the entry corresponding to GA:

‘HR

U SLUČAJU DODIRA S KOŽOM (ili kosom): odmah skinuti svu zagađenu odjeću. Isprati kožu vodom/tuširanjem.’

| (n) | in combined codes P304 + P340, the following is inserted after the entry corresponding to GA: | ‘HR | AKO SE UDIŠE: premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.’ |
| --- | --- | --- | --- |

(n)

in combined codes P304 + P340, the following is inserted after the entry corresponding to GA:

‘HR

AKO SE UDIŠE: premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.’

| (o) | in combined codes P308 + P311, the following is inserted after the entry corresponding to GA: | ‘HR | U SLUČAJU izloženosti ili sumnje na izloženost: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’ |
| --- | --- | --- | --- |

(o)

in combined codes P308 + P311, the following is inserted after the entry corresponding to GA:

‘HR

U SLUČAJU izloženosti ili sumnje na izloženost: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’

| (p) | in combined codes P342 + P311, the following is inserted after the entry corresponding to GA: | ‘HR | Pri otežanom disanju: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’ |
| --- | --- | --- | --- |

(p)

in combined codes P342 + P311, the following is inserted after the entry corresponding to GA:

‘HR

Pri otežanom disanju: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/...’

| (q) | in combined codes P361 + P364, the following is inserted after the entry corresponding to GA: | ‘HR | Odmah skinuti svu zagađenu odjeću i oprati je prije ponovne uporabe.’ |
| --- | --- | --- | --- |

(q)

in combined codes P361 + P364, the following is inserted after the entry corresponding to GA:

‘HR

Odmah skinuti svu zagađenu odjeću i oprati je prije ponovne uporabe.’

| (r) | in combined codes P362 + P364, the following is inserted after the entry corresponding to GA: | ‘HR | Skinuti zagađenu odjeću i oprati je prije ponovne uporabe.’ |
| --- | --- | --- | --- |

(r)

in combined codes P362 + P364, the following is inserted after the entry corresponding to GA:

‘HR

Skinuti zagađenu odjeću i oprati je prije ponovne uporabe.’

| (s) | in combined codes P370 + P378, the following is inserted after the entry corresponding to GA: | ‘HR | U slučaju požara: za gašenje rabiti ...’ |
| --- | --- | --- | --- |

(s)

in combined codes P370 + P378, the following is inserted after the entry corresponding to GA:

‘HR

U slučaju požara: za gašenje rabiti ...’

---

ANNEX III

Part 3 of Annex VI is amended as follows:

| (1) | Table 3.1 is amended as follows:






  (a) | the entry corresponding to index number 015-188-00-X is deleted; |
| --- | --- | --- |

(1)

Table 3.1 is amended as follows:

(a)

the entry corresponding to index number 015-188-00-X is deleted;

| (b) | the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5, 605-008-00-3 and 616-035-00-5 are replaced by the following corresponding entries:















  ‘006-086-00-6 | fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate | 276-696-7 | 72490-01-8 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | M = 1
  M = 10 000 | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 015-154-00-4 | ethephon; 2-chloroethylphosphonic acid | 240-718-3 | 16672-87-0 | Acute Tox. 3
  Acute Tox. 4
  Acute Tox. 4
  Skin Corr. 1C
  Aquatic Chronic 2 | H311
  H332
  H302
  H314
  H411 | GHS06
  GHS05
  GHS09
  Dgr | H311
  H332
  H302
  H314
  H411 | EUH071 | | |
| 015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate | 432-770-2 | 139189-30-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 601-023-00-4 | ethylbenzene | 202-849-4 | 100-41-4 | Flam. Liq. 2
  Acute Tox. 4*
  STOT RE 2
  Asp. Tox. 1 | H225
  H332
  H373 (hearing organs)
  H304 | GHS02
  GHS07
  GHS08
  Dgr | H225
  H332
  H373 (hearing organs)
  H304 | | | |
| 601-026-00-0 | styrene | 202-851-5 | 100-42-5 | Flam. Liq. 3
  Repr. 2
  Acute Tox. 4*
  STOT RE 1
  Skin Irrit. 2
  Eye Irrit. 2 | H226
  H361d
  H332
  H372 (hearing organs)
  H315
  H319 | GHS02
  GHS08
  GHS07
  Dgr | H226
  H361d
  H332
  H372 (hearing organs)
  H315
  H319 | | * | D |
| 603-061-00-7 | tetrahydro-2-furylmethanol;
  tetrahydrofurfuryl alcohol | 202-625-6 | 97-99-4 | Repr. 1B
  Eye Irrit. 2 | H360Df
  H319 | GHS08
  GHS07
  Dgr | H360Df
  H319 | | | |
| 605-001-00-5 | formaldehyde ...% | 200-001-8 | 50-00-0 | Carc. 1B
  Muta. 2
  Acute Tox. 3*
  Acute Tox. 3*
  Acute Tox. 3*
  Skin Corr. 1B
  Skin Sens. 1 | H350
  H341
  H301
  H311
  H331
  H314
  H317 | GHS08
  GHS06
  GHS05
  Dgr | H350
  H341
  H301
  H311
  H331
  H314
  H317 | | *
  Skin Corr. 1B; H314: C ≥ 25 %
  Skin Irrit. 2; H315: 5 % ≤ C < 25 %
  Eye Irrit. 2; H319: 5 % ≤ C < 25 %
  STOT SE 3; H335: C ≥ 5 %
  Skin Sens. 1; H317: C ≥ 0,2 % | B, D |
| 605-008-00-3 | acrolein;
  prop-2-enal;
  acrylaldehyde | 203-453-4 | 107-02-8 | Flam. Liq. 2
  Acute Tox. 1
  Acute Tox. 2
  Acute Tox. 3
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H330
  H300
  H311
  H314
  H400
  H410 | GHS02
  GHS06
  GHS05
  GHS09
  Dgr | H225
  H330
  H300
  H311
  H314
  H410 | EUH071 | Skin Corr. 1B;
  H314: C ≥ 0,1 %
  M = 100
  M = 1 | D |
| 616-035-00-5 | cymoxanil (ISO);
  2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Repr. 2
  Acute Tox. 4
  STOT RE 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361fd
  H302
  H373 (blood, thymus)
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361fd
  H302
  H373 (blood, thymus)
  H317
  H410 | | M = 1
  M = 1’ | |

(b)

the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5, 605-008-00-3 and 616-035-00-5 are replaced by the following corresponding entries:

‘006-086-00-6

fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate

276-696-7

72490-01-8

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 1

M = 10 000

015-154-00-4

ethephon; 2-chloroethylphosphonic acid

240-718-3

16672-87-0

Acute Tox. 3

Acute Tox. 4

Acute Tox. 4

Skin Corr. 1C

Aquatic Chronic 2

H311

H332

H302

H314

H411

GHS06

GHS05

GHS09

Dgr

H311

H332

H302

H314

H411

EUH071

015-192-00-1

tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate

432-770-2

139189-30-3

Skin Sens. 1

H317

GHS07

Wng

H317

601-023-00-4

ethylbenzene

202-849-4

100-41-4

Flam. Liq. 2

Acute Tox. 4*

STOT RE 2

Asp. Tox. 1

H225

H332

H373 (hearing organs)

H304

GHS02

GHS07

GHS08

Dgr

H225

H332

H373 (hearing organs)

H304

601-026-00-0

styrene

202-851-5

100-42-5

Flam. Liq. 3

Repr. 2

Acute Tox. 4*

STOT RE 1

Skin Irrit. 2

Eye Irrit. 2

H226

H361d

H332

H372 (hearing organs)

H315

H319

GHS02

GHS08

GHS07

Dgr

H226

H361d

H332

H372 (hearing organs)

H315

H319

*

D

603-061-00-7

tetrahydro-2-furylmethanol;

tetrahydrofurfuryl alcohol

202-625-6

97-99-4

Repr. 1B

Eye Irrit. 2

H360Df

H319

GHS08

GHS07

Dgr

H360Df

H319

605-001-00-5

formaldehyde ...%

200-001-8

50-00-0

Carc. 1B

Muta. 2

Acute Tox. 3*

Acute Tox. 3*

Acute Tox. 3*

Skin Corr. 1B

Skin Sens. 1

H350

H341

H301

H311

H331

H314

H317

GHS08

GHS06

GHS05

Dgr

H350

H341

H301

H311

H331

H314

H317

*

Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H315: 5 % ≤ C < 25 %

Eye Irrit. 2; H319: 5 % ≤ C < 25 %

STOT SE 3; H335: C ≥ 5 %

Skin Sens. 1; H317: C ≥ 0,2 %

B, D

605-008-00-3

acrolein;

prop-2-enal;

acrylaldehyde

203-453-4

107-02-8

Flam. Liq. 2

Acute Tox. 1

Acute Tox. 2

Acute Tox. 3

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H225

H330

H300

H311

H314

H400

H410

GHS02

GHS06

GHS05

GHS09

Dgr

H225

H330

H300

H311

H314

H410

EUH071

Skin Corr. 1B;

H314: C ≥ 0,1 %

M = 100

M = 1

D

616-035-00-5

cymoxanil (ISO);

2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide

261-043-0

57966-95-7

Repr. 2

Acute Tox. 4

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361fd

H302

H373 (blood, thymus)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361fd

H302

H373 (blood, thymus)

H317

H410

M = 1

M = 1’

| (c) | the following entries are inserted in accordance with the order of the entries set out in Table 3.1:















  ‘050-028-00-2 | 2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-829-0 | 57583-35-4 | Repr. 2
  Acute Tox. 4
  STOT RE 1
  Skin Sens. 1A | H361d
  H302
  H372 (nervous system, immune system)
  H317 | GHS08
  GHS07
  Dgr | H361d
  H302
  H372 (nervous system, immune system)
  H317 | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 050-029-00-8 | dimethyltin dichloride | 212-039-2 | 753-73-1 | Repr. 2
  Acute Tox. 2
  Acute Tox. 3
  Acute Tox. 3
  STOT RE 1
  Skin Corr. 1B | H361d
  H330
  H301
  H311
  H372 (nervous system, immune system)
  H314 | GHS08
  GHS06
  GHS05
  Dgr | H361d
  H330
  H301
  H311
  H372 (nervous system, immune system)
  H314 | EUH071 | | |
| 601-088-00-9 | 4-vinylcyclohexene | 202-848-9 | 100-40-3 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 601-089-00-4 | muscalure; cis-tricos-9-ene | 248-505-7 | 27519-02-4 | Skin Sens. 1B | H317 | GHS07
  Wng | H317 | | | |
| 604-090-00-8 | 4-tert-butylphenol | 202-679-0 | 98-54-4 | Repr. 2
  Skin Irrit. 2
  Eye Dam. 1 | H361f
  H315
  H318 | GHS08
  GHS05
  Dgr | H361f
  H315
  H318 | | | |
| 604-091-00-3 | etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether | 407-980-2 | 80844-07-1 | Lact.
  Aquatic Acute 1
  Aquatic Chronic 1 | H362
  H400
  H410 | GHS09
  Wng | H362
  H410 | | M = 100
  M = 1 000 | |
| 606-146-00-7 | tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one | - | 87820-88-0 | Carc. 2
  Acute Tox. 4
  Aquatic Chronic 2 | H351
  H302
  H411 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H411 | | | |
| 606-147-00-2 | cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one | 405-230-9 | 101205-02-1 | Repr. 2 | H361d | GHS08
  Wng | H361d | | | |
| 607-705-00-8 | benzoic acid | 200-618-2 | 65-85-0 | STOT RE 1
  Skin Irrit. 2
  Eye Dam. 1 | H372 (lungs) (inhalation)
  H315
  H318 | GHS08
  GHS05
  Dgr | H372 (lungs) (inhalation)
  H315
  H318 | | | |
| 607-706-00-3 | methyl 2,5-dichlorobenzoate | 220-815-7 | 2905-69-3 | Acute Tox. 4
  STOT SE 3
  Aquatic Chronic 2 | H302
  H336
  H411 | GHS07
  GHS09
  Wng | H302
  H336
  H411 | | | |
| 612-287-00-5 | fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine | - | 79622-59-6 | Repr. 2
  Acute Tox. 4
  Eye Dam. 1
  Skin Sens. 1A
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d
  H332
  H318
  H317
  H400
  H410 | GHS08
  GHS07
  GHS05
  GHS09
  Dgr | H361d
  H332
  H318
  H317
  H410 | | M = 10
  M = 10 | |
| 613-317-00-X | penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole | 266-275-6 | 66246-88-6 | Repr. 2
  Acute Tox. 4
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361d
  H302
  H410 | | M = 1
  M = 1 | |
| 613-318-00-5 | fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate | - | 473798-59-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 616-212-00-7 | 3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate | 259-627-5 | 55406-53-6 | Acute Tox. 3
  Acute Tox. 4
  STOT RE 1
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H302
  H372 (larynx)
  H318
  H317
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H331
  H302
  H372 (larynx)
  H318
  H317
  H410 | | M = 10
  M = 1’ | |

(c)

the following entries are inserted in accordance with the order of the entries set out in Table 3.1:

‘050-028-00-2

2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

260-829-0

57583-35-4

Repr. 2

Acute Tox. 4

STOT RE 1

Skin Sens. 1A

H361d

H302

H372 (nervous system, immune system)

H317

GHS08

GHS07

Dgr

H361d

H302

H372 (nervous system, immune system)

H317

050-029-00-8

dimethyltin dichloride

212-039-2

753-73-1

Repr. 2

Acute Tox. 2

Acute Tox. 3

Acute Tox. 3

STOT RE 1

Skin Corr. 1B

H361d

H330

H301

H311

H372 (nervous system, immune system)

H314

GHS08

GHS06

GHS05

Dgr

H361d

H330

H301

H311

H372 (nervous system, immune system)

H314

EUH071

601-088-00-9

4-vinylcyclohexene

202-848-9

100-40-3

Carc. 2

H351

GHS08

Wng

H351

601-089-00-4

muscalure; cis-tricos-9-ene

248-505-7

27519-02-4

Skin Sens. 1B

H317

GHS07

Wng

H317

604-090-00-8

4-tert-butylphenol

202-679-0

98-54-4

Repr. 2

Skin Irrit. 2

Eye Dam. 1

H361f

H315

H318

GHS08

GHS05

Dgr

H361f

H315

H318

604-091-00-3

etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether

407-980-2

80844-07-1

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H362

H400

H410

GHS09

Wng

H362

H410

M = 100

M = 1 000

606-146-00-7

tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one

-

87820-88-0

Carc. 2

Acute Tox. 4

Aquatic Chronic 2

H351

H302

H411

GHS08

GHS07

GHS09

Wng

H351

H302

H411

606-147-00-2

cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one

405-230-9

101205-02-1

Repr. 2

H361d

GHS08

Wng

H361d

607-705-00-8

benzoic acid

200-618-2

65-85-0

STOT RE 1

Skin Irrit. 2

Eye Dam. 1

H372 (lungs) (inhalation)

H315

H318

GHS08

GHS05

Dgr

H372 (lungs) (inhalation)

H315

H318

607-706-00-3

methyl 2,5-dichlorobenzoate

220-815-7

2905-69-3

Acute Tox. 4

STOT SE 3

Aquatic Chronic 2

H302

H336

H411

GHS07

GHS09

Wng

H302

H336

H411

612-287-00-5

fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine

-

79622-59-6

Repr. 2

Acute Tox. 4

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H361d

H332

H318

H317

H400

H410

GHS08

GHS07

GHS05

GHS09

Dgr

H361d

H332

H318

H317

H410

M = 10

M = 10

613-317-00-X

penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole

266-275-6

66246-88-6

Repr. 2

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H361d

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H361d

H302

H410

M = 1

M = 1

613-318-00-5

fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate

-

473798-59-3

Aquatic Chronic 2

H411

GHS09

H411

616-212-00-7

3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate

259-627-5

55406-53-6

Acute Tox. 3

Acute Tox. 4

STOT RE 1

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H302

H372 (larynx)

H318

H317

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H331

H302

H372 (larynx)

H318

H317

H410

M = 10

M = 1’

| (2) | Table 3.2 is amended as follows:






  (a) | the entry corresponding to index number 015-188-00-X is deleted; |
| --- | --- | --- |

(2)

Table 3.2 is amended as follows:

(a)

the entry corresponding to index number 015-188-00-X is deleted;

| (b) | the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5 and 616-035-00-5 are replaced by the following corresponding entries:












  ‘006-086-00-6 | fenoxycarb (ISO);ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate | 276-696-7 | 72490-01-8 | Carc. Cat. 3; R40
  N; R50-53 | Xn; N
  R: 40-50/53
  S: (2-)22-36/37-60-61 | N; R50-53: C ≥ 25 %
  N; R51-53: 2,5 % ≤ C < 25 %
  R52-53: 0,25 % ≤ C < 2,5 % | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 015-154-00-4 | ethephon; 2-chloroethylphosphonic acid | 240-718-3 | 16672-87-0 | C; R34
  Xn; R20/21/22
  N; R51-53 | C; N
  R: 20/21/22-34-51/53
  S: (1/2-)26-36/37/39-45-61 | Xi; R37: 5 % ≤ C < 10 % | |
| 015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate | 432-770-2 | 139189-30-3 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 601-023-00-4 | ethylbenzene | 202-849-4 | 100-41-4 | F; R11
  Xn; R20-48/20-65 | F; Xn
  R: 11-20-48/20-65
  S: (2-)16-24/25-29-62 | | |
| 601-026-00-0 | styrene | 202-851-5 | 100-42-5 | Repr. Cat. 3; R63
  Xn; R20-48/20
  Xi; R36/38
  R10 | Xn
  R: 10-20-36/38-48/20-63
  S: (2-)23-36/37-46 | Xn; R20: C ≥ 12,5 %
  Xi; R36/38: C ≥ 12,5 % | D |
| 603-061-00-7 | tetrahydro-2-furylmethanol;
  tetrahydrofurfuryl alcohol | 202-625-6 | 97-99-4 | Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  Xi; R36 | T
  R: 36-61-62
  S: 45-53 | Xi; R36: C ≥ 10 % | |
| 605-001-00-5 | formaldehyde ...% | 200-001-8 | 50-00-0 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  T; R23/24/25
  C; R34
  R43 | T
  R: 23/24/25-34-43-45-68
  S: 45-53 | T; R23/24/25: C ≥ 25 %
  Xn; R20/21/22: 5 % ≤ C < 25 %
  C; R34: C ≥ 25 %
  Xi; R36/37/38: 5 % ≤ C < 25 %
  R43: C ≥ 0,2 % | B, D |
| 616-035-00-5 | cymoxanil (ISO);
  2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Repr. Cat. 3; R62-63
  Xn; R22-48/22
  R43
  N; R50-53 | Xn; N
  R: 22-43-48/22-62-63-50/53
  S: (2-)36/37-46-60-61 | N; R50-53: C ≥ 25 %
  N; R51-53: 2,5 % ≤ C < 25 %
  R52-53: 0,25 % ≤ C < 2,5 %’ | |

(b)

the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5 and 616-035-00-5 are replaced by the following corresponding entries:

‘006-086-00-6

fenoxycarb (ISO);ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate

276-696-7

72490-01-8

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)22-36/37-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

015-154-00-4

ethephon; 2-chloroethylphosphonic acid

240-718-3

16672-87-0

C; R34

Xn; R20/21/22

N; R51-53

C; N

R: 20/21/22-34-51/53

S: (1/2-)26-36/37/39-45-61

Xi; R37: 5 % ≤ C < 10 %

015-192-00-1

tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate

432-770-2

139189-30-3

R43

Xi

R: 43

S: (2-)24-37

601-023-00-4

ethylbenzene

202-849-4

100-41-4

F; R11

Xn; R20-48/20-65

F; Xn

R: 11-20-48/20-65

S: (2-)16-24/25-29-62

601-026-00-0

styrene

202-851-5

100-42-5

Repr. Cat. 3; R63

Xn; R20-48/20

Xi; R36/38

R10

Xn

R: 10-20-36/38-48/20-63

S: (2-)23-36/37-46

Xn; R20: C ≥ 12,5 %

Xi; R36/38: C ≥ 12,5 %

D

603-061-00-7

tetrahydro-2-furylmethanol;

tetrahydrofurfuryl alcohol

202-625-6

97-99-4

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xi; R36

T

R: 36-61-62

S: 45-53

Xi; R36: C ≥ 10 %

605-001-00-5

formaldehyde ...%

200-001-8

50-00-0

Carc. Cat. 2; R45

Muta. Cat. 3; R68

T; R23/24/25

C; R34

R43

T

R: 23/24/25-34-43-45-68

S: 45-53

T; R23/24/25: C ≥ 25 %

Xn; R20/21/22: 5 % ≤ C < 25 %

C; R34: C ≥ 25 %

Xi; R36/37/38: 5 % ≤ C < 25 %

R43: C ≥ 0,2 %

B, D

616-035-00-5

cymoxanil (ISO);

2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide

261-043-0

57966-95-7

Repr. Cat. 3; R62-63

Xn; R22-48/22

R43

N; R50-53

Xn; N

R: 22-43-48/22-62-63-50/53

S: (2-)36/37-46-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %’

| (c) | the following entries are inserted in accordance with the order of the entries set out in Table 3.2:












  ‘050-028-00-2 | 2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-829-0 | 57583-35-4 | Repr. Cat. 3; R63
  T; R48/25
  Xn; R22
  R43 | T
  R: 22-43-48/25-63
  S: (1/2-)36/37-45 | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 050-029-00-8 | dimethyltin dichloride | 212-039-2 | 753-73-1 | Repr. Cat. 3; R63
  T+; R26
  T; R24/25-48/25
  C; R34 | T+
  R: 24/25-26-34-48/25-63
  S: (1/2-)26-28-36/37/39-45-63 | | |
| 601-088-00-9 | 4-vinylcyclohexene | 202-848-9 | 100-40-3 | Carc. Cat. 3; R40 | Xn
  R: 40
  S: (2-)36/37 | | |
| 601-089-00-4 | muscalure; cis-tricos-9-ene | 248-505-7 | 27519-02-4 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 604-090-00-8 | 4-tert-butylphenol | 202-679-0 | 98-54-4 | Repr. Cat. 3; R62
  Xi; R38-41 | Xn
  R: 38-41-62
  S: (2-)26-36/37/39-46 | | |
| 604-091-00-3 | etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether | 407-980-2 | 80844-07-1 | R64
  N; R50-53 | N
  R: 50/53-64
  S: 60-61 | N; R50-53: C ≥ 0,25 %
  N; R51-53: 0,025 % ≤ C < 0,25 %
  R52-53: 0,0025 % ≤ C < 0,025 % | |
| 606-146-00-7 | tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one | – | 87820-88-0 | Carc. Cat. 3; R40
  Xn; R22
  N; R51-53 | Xn; N
  R: 22-40-51/53
  S: (2-)36/37-60-61 | | |
| 606-147-00-2 | cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one | 405-230-9 | 101205-02-1 | F; R11
  Repr. Cat. 3; R63 | F; Xn
  R: 11-63
  S: (2-)16-36/37-46 | | |
| 607-705-00-8 | benzoic acid | 200-618-2 | 65-85-0 | T; R48/23
  Xi; R38-41 | T
  R: 38-41-48/23
  S: (1/2-)26-39-45-63 | | |
| 607-706-00-3 | methyl 2,5-dichlorobenzoate | 220-815-7 | 2905-69-3 | Xn; R22
  N; R51-53 | Xn; N
  R: 22-51/53
  S: (2-) 46-61 | | |
| 612-287-00-5 | fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine | - | 79622-59-6 | Repr. Cat. 3; R63
  Xn; R20
  Xi; R41
  R43
  N; R50-53 | Xn; N
  R: 20-41-43-50/53-63
  S: (2-)26-36/37/39-46-60-61 | N; R50-53: C ≥ 2,5 %
  N; R51-53: 0,25 % ≤ C < 2,5 %
  R52-53: 0,025 % ≤ C < 0,25 % | |
| 613-317-00-X | penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole | 266-275-6 | 66246-88-6 | Repr. Cat. 3; R63
  Xn; R22
  N; R50-53 | Xn; N
  R: 22-50/53-63
  S: (2-) 36/37-46-60-61 | N; R50-53: C ≥ 25 %
  N; R51-53: 2,5 % ≤ C < 25 %
  R52-53: 0,25 % ≤ C < 2,5 % | |
| 613-318-00-5 | fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate | - | 473798-59-3 | N; R51-53 | N
  R: 51/53
  S: 60-61 | | |
| 616-212-00-7 | 3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate | 259-627-5 | 55406-53-6 | T; R23-48/23
  Xn; R22
  Xi; R41
  R43
  N; R50 | T; N
  R: 22-23-41-43-48/23-50
  S: (1/2-)24-26-37/39-45-63 | N; R50: C ≥ 2,5 %’ | |

(c)

the following entries are inserted in accordance with the order of the entries set out in Table 3.2:

‘050-028-00-2

2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

260-829-0

57583-35-4

Repr. Cat. 3; R63

T; R48/25

Xn; R22

R43

T

R: 22-43-48/25-63

S: (1/2-)36/37-45

050-029-00-8

dimethyltin dichloride

212-039-2

753-73-1

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/25

C; R34

T+

R: 24/25-26-34-48/25-63

S: (1/2-)26-28-36/37/39-45-63

601-088-00-9

4-vinylcyclohexene

202-848-9

100-40-3

Carc. Cat. 3; R40

Xn

R: 40

S: (2-)36/37

601-089-00-4

muscalure; cis-tricos-9-ene

248-505-7

27519-02-4

R43

Xi

R: 43

S: (2-)24-37

604-090-00-8

4-tert-butylphenol

202-679-0

98-54-4

Repr. Cat. 3; R62

Xi; R38-41

Xn

R: 38-41-62

S: (2-)26-36/37/39-46

604-091-00-3

etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether

407-980-2

80844-07-1

R64

N; R50-53

N

R: 50/53-64

S: 60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

606-146-00-7

tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one

–

87820-88-0

Carc. Cat. 3; R40

Xn; R22

N; R51-53

Xn; N

R: 22-40-51/53

S: (2-)36/37-60-61

606-147-00-2

cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one

405-230-9

101205-02-1

F; R11

Repr. Cat. 3; R63

F; Xn

R: 11-63

S: (2-)16-36/37-46

607-705-00-8

benzoic acid

200-618-2

65-85-0

T; R48/23

Xi; R38-41

T

R: 38-41-48/23

S: (1/2-)26-39-45-63

607-706-00-3

methyl 2,5-dichlorobenzoate

220-815-7

2905-69-3

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-) 46-61

612-287-00-5

fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine

-

79622-59-6

Repr. Cat. 3; R63

Xn; R20

Xi; R41

R43

N; R50-53

Xn; N

R: 20-41-43-50/53-63

S: (2-)26-36/37/39-46-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

613-317-00-X

penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole

266-275-6

66246-88-6

Repr. Cat. 3; R63

Xn; R22

N; R50-53

Xn; N

R: 22-50/53-63

S: (2-) 36/37-46-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

613-318-00-5

fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate

-

473798-59-3

N; R51-53

N

R: 51/53

S: 60-61

616-212-00-7

3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate

259-627-5

55406-53-6

T; R23-48/23

Xn; R22

Xi; R41

R43

N; R50

T; N

R: 22-23-41-43-48/23-50

S: (1/2-)24-26-37/39-45-63

N; R50: C ≥ 2,5 %’

---